rs189277711
Positions:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_001009944.3(PKD1):c.6927C>T(p.Gly2309=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0179 in 1,553,324 control chromosomes in the GnomAD database, including 308 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.014 ( 24 hom., cov: 33)
Exomes 𝑓: 0.018 ( 284 hom. )
Consequence
PKD1
NM_001009944.3 synonymous
NM_001009944.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.39
Genes affected
PKD1 (HGNC:9008): (polycystin 1, transient receptor potential channel interacting) This gene encodes a member of the polycystin protein family. The encoded glycoprotein contains a large N-terminal extracellular region, multiple transmembrane domains and a cytoplasmic C-tail. It is an integral membrane protein that functions as a regulator of calcium permeable cation channels and intracellular calcium homoeostasis. It is also involved in cell-cell/matrix interactions and may modulate G-protein-coupled signal-transduction pathways. It plays a role in renal tubular development, and mutations in this gene cause autosomal dominant polycystic kidney disease type 1 (ADPKD1). ADPKD1 is characterized by the growth of fluid-filled cysts that replace normal renal tissue and result in end-stage renal failure. Splice variants encoding different isoforms have been noted for this gene. Also, six pseudogenes, closely linked in a known duplicated region on chromosome 16p, have been described. [provided by RefSeq, Oct 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 16-2108021-G-A is Benign according to our data. Variant chr16-2108021-G-A is described in ClinVar as [Benign]. Clinvar id is 256994.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2108021-G-A is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=-1.39 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0138 (2097/152288) while in subpopulation NFE AF= 0.0195 (1323/68004). AF 95% confidence interval is 0.0186. There are 24 homozygotes in gnomad4. There are 1040 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High AC in GnomAd4 at 2097 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PKD1 | NM_001009944.3 | c.6927C>T | p.Gly2309= | synonymous_variant | 16/46 | ENST00000262304.9 | NP_001009944.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PKD1 | ENST00000262304.9 | c.6927C>T | p.Gly2309= | synonymous_variant | 16/46 | 1 | NM_001009944.3 | ENSP00000262304 | P5 |
Frequencies
GnomAD3 genomes AF: 0.0138 AC: 2097AN: 152170Hom.: 24 Cov.: 33
GnomAD3 genomes
AF:
AC:
2097
AN:
152170
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0131 AC: 2000AN: 152096Hom.: 39 AF XY: 0.0130 AC XY: 1071AN XY: 82084
GnomAD3 exomes
AF:
AC:
2000
AN:
152096
Hom.:
AF XY:
AC XY:
1071
AN XY:
82084
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0184 AC: 25727AN: 1401036Hom.: 284 Cov.: 31 AF XY: 0.0180 AC XY: 12434AN XY: 691940
GnomAD4 exome
AF:
AC:
25727
AN:
1401036
Hom.:
Cov.:
31
AF XY:
AC XY:
12434
AN XY:
691940
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0138 AC: 2097AN: 152288Hom.: 24 Cov.: 33 AF XY: 0.0140 AC XY: 1040AN XY: 74476
GnomAD4 genome
AF:
AC:
2097
AN:
152288
Hom.:
Cov.:
33
AF XY:
AC XY:
1040
AN XY:
74476
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
10
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Mar 04, 2020 | - - |
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Oct 17, 2019 | This variant is associated with the following publications: (PMID: 11967008, 11857740, 10854095) - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Polycystic kidney disease, adult type Benign:1
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Mar 23, 2020 | - - |
Polycystic kidney disease Benign:1
Benign, no assertion criteria provided | clinical testing | Department of Pathology and Laboratory Medicine, Sinai Health System | - | The PKD1 p.Gly2309Gly variant was identified in 17 of 732 proband chromosomes (frequency: 0.023) from individuals or families with ADPKD or renal disease, and was not identified in 100 control chromosomes from healthy individuals (Bataille 2011, Garcia-Gonzalez 2007, McCluskey 2002, Rossetti 2012). The above studies determined this variant to be classified as a polymorphism based on either it being a synonymous variant, in silico analysis or interspecies conservation. The p.Gly2309Gly variant was identified in the dbSNP (ID: rs189277711) with unknown clinical significance with a minor allele frequency 0.0082 (41 of 5000 chromosomes in 1000 Genome Project). In the NHLBI Exome Sequencing Project, the variant was identified in 119 of 7256 alleles (frequency: 0.0164) in European Americans and 10 of 3486 African Americans (frequency: 0.00286). The variant was identified in the Exome Aggregation Consortium database (March 14, 2016) in 214 of 15790 alleles, 5 of which are homozygous (frequency: 0.0135) or 6 of 56 of European (Finnish), 138 of 5652 European (Non-Finnish), 8 of 380 Latino, 7 of 1120 African, 54 of 7844 South Asians, 1 of 168 other alleles and was not found in East Asians. The variant was identified in the ADPKD Mutation Database and classified as likely neutral. The c.6927C>T variant occurs outside of the splicing consensus sequence and 4 of 5 in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) predict a location change of a cryptic 5’ splice donor site; this is not very predictive of pathogenicity. The p.Gly2309Gly variant is not expected to have clinical significance because it does not result in a change of amino acid and is not located in a known consensus splice site. In addition this variant was identified by our laboratory as co-occurring with pathogenic PKD1 variants in two different families with polycystic kidney disease (PKD1, EXON43, c.11798_11810del, p.Leu3933ArgfsX8 and c.2215C>T, p.Gln739X), increasing the likelihood that this variant does not have clinical significance. In summary, based on the above information, this variant meets our criteria to be classified as benign. - |
Autosomal dominant polycystic kidney disease Benign:1
Benign, criteria provided, single submitter | research | Molecular Genetics of Inherited Kidney Disorders Laboratory, Garvan Institute of Medical Research | Jan 01, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at